{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Requena-Ocana N"],"funding":["Instituto de Salud Carlos III","PFIS” Predoctoral research contract","'Sara Borrell' Research Contract","PFIS\" Predoctoral research contract"],"pagination":["947"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9138236"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(5)"],"pubmed_abstract":["(1) Background: Alcohol Use Disorder (AUD) is associated with functional disruption of several brain structures that may trigger cognitive dysfunction. One of the mechanisms of alcohol-associated cognitive impairment has been proposed to arise from its direct impact on the immune system, which culminates in the release of cytokines and chemokines which can eventually reach the brain. Alcohol can also disrupt the blood-brain barrier, facilitating the penetration of pro-inflammatory molecules throughout vascular endothelial growth factor A (VEGFA). Thus, alcohol-induced alterations in chemokines and VEGFA might contribute to the neuroinflammation and cognitive impairment associated with AUD. (2) Methods: The present cross-sectional study investigates whether patients with AUD (<i>n</i> = 86)"],"journal":["Biomedicines"],"pubmed_title":["Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder."],"pmcid":["PMC9138236"],"funding_grant_id":["(FI18/00249) financed by ISCIII ERDF/ESF","(CD19/00019) financed by ISCIII and ERDF-EU.","RD16/0017/0001; , ERDF-EU PI17/02026 and PI19/01577"],"pubmed_authors":["Serrano A","Farre M","Rodriguez de Fonseca F","Requena-Ocana N","Suarez J","Ortega-Pinazo J","Pavon-Moron FJ","Garcia-Marchena N","Ruiz JJ","Papaseit E","Araos P","Flores-Lopez M"],"additional_accession":[]},"is_claimable":false,"name":"Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder.","description":"(1) Background: Alcohol Use Disorder (AUD) is associated with functional disruption of several brain structures that may trigger cognitive dysfunction. One of the mechanisms of alcohol-associated cognitive impairment has been proposed to arise from its direct impact on the immune system, which culminates in the release of cytokines and chemokines which can eventually reach the brain. Alcohol can also disrupt the blood-brain barrier, facilitating the penetration of pro-inflammatory molecules throughout vascular endothelial growth factor A (VEGFA). Thus, alcohol-induced alterations in chemokines and VEGFA might contribute to the neuroinflammation and cognitive impairment associated with AUD. (2) Methods: The present cross-sectional study investigates whether patients with AUD (<i>n</i> = 86)","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2026-05-07T03:10:14.583Z","creation":"2025-02-19T02:58:36.423Z"},"accession":"S-EPMC9138236","cross_references":{"pubmed":["35625687"],"doi":["10.3390/biomedicines10050947"]}}